117 results
Page 4 of 6
6-K
EX-99.1
ngb0146dye2v43jvrj1
6 Aug 19
Notice of Annual and Special Meeting of Shareholders
12:00am
POS AM
95dedw20q6
15 Jul 19
Prospectus update (post-effective amendment)
5:15pm
6-K
EX-99.1
x62qak1iz3165zu6k
14 Feb 19
At Market Issuance Sales Agreement
8:13am
424B5
68l2bm9hw 1p
14 Feb 19
Prospectus supplement for primary offering
8:06am
6-K
EX-99.1
10t48
14 Feb 19
Current report (foreign)
7:55am
6-K
EX-99.1
94k7w5
14 Nov 18
Current report (foreign)
7:00am
POS AM
2nkbpxjz mnah
12 Oct 18
Prospectus update (post-effective amendment)
5:05pm
6-K
EX-99.1
1bypb2 45a256r1ox
9 Oct 18
Current report (foreign)
5:21pm
424B5
sxqnuruq gp7
5 Oct 18
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
qa8iig85
4 Oct 18
Acasti Pharma Prices C$24 Million Underwritten Offering
11:00am
6-K
EX-99.1
y99nravmpogv2 nfh
3 Oct 18
Acasti Pharma Announces Public Equity Offering
5:15pm
424B5
u19 1ueap
3 Oct 18
Prospectus supplement for primary offering
4:51pm
6-K
EX-99.1
058p39wbt l5ffm
14 Aug 18
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2019
1:04pm
6-K
EX-99.1
n4yvzt yhi
14 Aug 18
Current report (foreign)
7:00am
6-K
EX-99.2
63hmnqcwugye5ici
1 Aug 18
Notice of Annual and Special Meeting of Shareholders
12:00am
6-K
EX-99.2
au5oqh5
27 Jun 18
Current report (foreign)
5:27pm
6-K
EX-99.1
ljoywr
27 Jun 18
Current report (foreign)
5:27pm
6-K
EX-99.1
lu09tvr6atnvfxag6
27 Jun 18
Acasti Pharma Business Update for the Fourth Quarter and Fiscal 2018
5:01pm